XTRA:1SXPLife Sciences
A Look At SCHOTT Pharma KGaA (XTRA:1SXP) Valuation After Weaker Profitability In Latest Earnings
Why SCHOTT Pharma KGaA’s Latest Earnings Matter for the Stock
SCHOTT Pharma KGaA (XTRA:1SXP) released second quarter and six month results to March 31, 2026, reporting relatively stable sales but lower net income and earnings per share compared with the prior year period.
See our latest analysis for SCHOTT Pharma KGaA.
The earnings release arrived after a weak year for investors, with a 1-year total shareholder return that declined 43.69%, even as share price momentum has recently improved...